Efficacy and Safety Trial of 12 Weeks of Treatment With Nebulized SUN-101 in Patients With COPD
Public ClinicalTrials.gov record NCT02347761. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Trial of 12 Weeks of Treatment With Nebulized SUN-101 in Patients With COPD: GOLDEN-3 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a trial of 12 weeks of treatment with nebulized SUN-101 using an Investigational eFlow® Closed System (CS) nebulizer in subjects with chronic obstructive pulmonary disease (COPD) according to the Global Initiative for Chronic Obstructive Lung Disease (GOLD 2014) guidelines.
Study identification
- NCT ID
- NCT02347761
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 653 participants
Conditions and interventions
Conditions
Interventions
- SUN-101 50 mcg BID eFlow (CS) nebulizer Drug
- SUN-101 25 mcg BID eFlow (CS) nebulizer Drug
- Placebo BID eFlow Closed System (CS) nebulizer Drug
Drug
Eligibility (public fields only)
- Age range
- 40 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 31, 2015
- Primary completion
- Oct 31, 2015
- Completion
- Oct 31, 2015
- Last update posted
- Mar 21, 2018
2015
United States locations
- U.S. sites
- 44
- U.S. states
- 18
- U.S. cities
- 39
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Pinnacle Research Group, LLC | Anniston | Alabama | 36207 | — |
| Pulmonary Associates, PA | Phoenix | Arizona | 85006 | — |
| Clinical Research Consortium - Arizona | Tempe | Arizona | 85283 | — |
| Desert Sun Clinical Research, LLC | Tucson | Arizona | 85710 | — |
| Western States Clinical Research, Inc. | Wheat Ridge | Colorado | 80033 | — |
| Clinical Research of West Florida, Inc. | Clearwater | Florida | 33765 | — |
| Clermont Medical Research | Clermont | Florida | 34711 | — |
| Riverside Clinical Research | Edgewater | Florida | 32132 | — |
| Pulmonary Disease Specialists, PA, d/b/a PDS Research | Kissimmee | Florida | 34741 | — |
| AppleMed Research, Inc. | Miami | Florida | 33155 | — |
| Clinical Trials of Florida, LLC | Miami | Florida | 33186 | — |
| Florida Institute for Clinical Research, LLC | Orlando | Florida | 32825 | — |
| Emerald Coast Research Associates | Panama City | Florida | 32405 | — |
| Clinical Research of West Florida, Inc | Tampa | Florida | 33603 | — |
| Abraham Reasearch, PLLC | Fort Mitchell | Kentucky | 41017 | — |
| Pulmonary Research Institute of Southeast Michigan | Livonia | Michigan | 48152 | — |
| Minnesota Lung Center | Edina | Minnesota | 55435 | — |
| Minnesota Lung Center | Woodbury | Minnesota | 55125 | — |
| Midwest Chest Consultants, P.C. | Saint Charles | Missouri | 63301 | — |
| Clinical Research Consortium | Las Vegas | Nevada | 89119 | — |
| AAIR Research Center | Rochester | New York | 14618 | — |
| American Health Research, Inc. | Charlotte | North Carolina | 28207 | — |
| Hickory Research Center | Hickory | North Carolina | 28602 | — |
| North Carolina Clinical Research | Raleigh | North Carolina | 27607 | — |
| PMG Research of Wilmington | Wilmington | North Carolina | 28401 | — |
| Columbus Regional Research Institute | Columbus | Ohio | 31904 | — |
| Columbus Clinical Research, Inc | Columbus | Ohio | 43213 | — |
| Optimed Research, LTD | Columbus | Ohio | 43235 | — |
| Clinical Research Institute of Southern Oregon, PC | Medford | Oregon | 97504 | — |
| Research Protocol Management Specialists | Pittsburgh | Pennsylvania | 15243 | — |
| Safe Harbor Clinical Research | East Providence | Rhode Island | 02914 | — |
| Palmetto Medical Research Associates, LLC | Easley | South Carolina | 29640 | — |
| Greenville Pharmaceutical Research, Inc | Greenville | South Carolina | 29615 | — |
| Upstate Pharmaceutical Research | Greenville | South Carolina | 29615 | — |
| Piedmont Research Partners, LLC | Old Point Station | South Carolina | 29707 | — |
| S. Carolina Pharmaceutical Research | Spartanburg | South Carolina | 29303 | — |
| Spartanburg Medical Research | Spartanburg | South Carolina | 29303 | — |
| CU Pharmaceutical Research | Union | South Carolina | 29379 | — |
| Texas Pulmonary and Critical Care Consultants, PA | Fort Worth | Texas | 76104 | — |
| Pioneer Research Solutions, Inc. | Houston | Texas | 77099 | — |
| Central Texas Health Research | New Braunfels | Texas | 78130 | — |
| Sylvana Research Associates | San Antonio | Texas | 78229 | — |
| Pulmonary Research of Abingdon, LLC | Abingdon | Virginia | 24210 | — |
| Pulmonary Associates of Richmond, Inc. | Richmond | Virginia | 23225 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02347761, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 21, 2018 · Synced Sep 3, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02347761 live on ClinicalTrials.gov.